Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HSD17B11 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | ALDH1L2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | LMO2 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | TOP1MT | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | RP11-307N16.6 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | KRBOX4 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
mRNA | MGST2 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
mRNA | P3H3 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-07 |
mRNA | EPS8L3 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |